Literature DB >> 12738117

Prenatal diagnosis of methotrexate embryopathy.

Jeff B Chapa1, Judith U Hibbard, Elyse M Weber, Jacques S Abramowicz, Marion S Verp.   

Abstract

BACKGROUND: Methotrexate is an antineoplastic agent used by obstetrician-gynecologists for termination of early pregnancy. The drug is not always successful and is associated with a known array of malformations. CASE: We present a case of a failed pregnancy termination with methotrexate, which resulted in fetal anomalies. Ultrasound revealed absent or markedly shortened long bones, abnormal positioning of the hands, micrognathia, echogenic bowel, and a two-vessel umbilical cord. The patient elected to undergo pregnancy termination, and the ultrasound findings were confirmed at autopsy.
CONCLUSION: Because of methotrexate's teratogenic potential, follow-up to confirm successful termination is necessary. Ultrasound evaluation of the fetus is indicated if pregnancy termination is unsuccessful.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738117     DOI: 10.1016/s0029-7844(03)00120-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.

Authors:  Fokaline Vroom; Hermien E K de Walle; Mart A J F van de Laar; Jacobus R B J Brouwers; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Fetal Anomalies in Rheumatoid Arthritis Patient Exposed to Low Dose Methotrexate.

Authors:  Y Singh; A Shankar
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Maternal exposure to methotrexate and birth defects: a population-based study.

Authors:  April L Dawson; Tiffany Riehle-Colarusso; Jennita Reefhuis; J Fernando Arena
Journal:  Am J Med Genet A       Date:  2014-06-04       Impact factor: 2.802

4.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.